-
Je něco špatně v tomto záznamu ?
A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology
J Bartek, B Vojtesek, Z Staskova, J Bartkova, Z Kerekes, A Rejthar, J Kovarik
Jazyk angličtina Země Anglie, Velká Británie
Grantová podpora
IZ95
MZ0
CEP - Centrální evidence projektů
IZ92
MZ0
CEP - Centrální evidence projektů
PubMed
1716305
DOI
10.1002/path.1711640306
Knihovny.cz E-zdroje
- MeSH
- 2D gelová elektroforéza MeSH
- buněčné linie MeSH
- epitel imunologie MeSH
- fluorescenční protilátková technika MeSH
- imunoblotting MeSH
- keratiny analýza imunologie MeSH
- lidé MeSH
- monoklonální protilátky diagnostické užití imunologie MeSH
- myši MeSH
- nádory chemie imunologie patologie MeSH
- specificita protilátek MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
A series of 14 new mouse monoclonal antibodies (MAbs) to keratins is described and the data suggesting their potential value in the differential diagnosis of human tumours are reported. The specificities of individual MAbs of the 'C-series' presented here range from monospecificity for keratin No. 7 (MAbs C-18, C-35, C-62, and C-68), keratin No. 8 (MAbs C-15, C-43, and C-15), and keratin No. 18 (MAbs C-04 and C-08) up to the broadly reacting 'pan-keratin' MAb C-11, with the target epitopes of the remaining four MAbs being shared by different pairs of keratin polypeptides. The results of the biochemical characterization of the MAbs, together with their immunohistochemical staining patterns on frozen as well as on paraffin sections of normal human tissues, suggest that they represent a significant contribution to the growing list of anti-keratin MAbs applicable in both research and routine diagnostic pathology. The immunohistochemical examination of a wide range of human neoplasms with the new MAbs not only confirmed their value in making distinctions between carcinomas, on the one hand, and lymphomas, and gliomas, on the other, but also verified the possibility of more subtle subdivisions within the group of adenocarcinomas and their metastases. Furthermore, the identification of small subsets of breast carcinomas with decreased levels or apparent loss of the keratin No. 7 polypeptide and some cases of stomach carcinoma with apparently induced expression of this keratin suggests that such 'exceptions' must be considered when using keratin spectra as one of the criteria in differential diagnosis.
Department of Pathology Charles University Medical School Hradec Králové Czechoslovakia
Research Institute of Clinical and Experimental Oncology Brno Czechoslovakia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13027817
- 003
- CZ-PrNML
- 005
- 20131203144242.0
- 007
- ta
- 008
- 130827s1991 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/path.1711640306 $2 doi
- 035 __
- $a (PubMed)1716305
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia.
- 245 12
- $a A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology / $c J Bartek, B Vojtesek, Z Staskova, J Bartkova, Z Kerekes, A Rejthar, J Kovarik
- 520 9_
- $a A series of 14 new mouse monoclonal antibodies (MAbs) to keratins is described and the data suggesting their potential value in the differential diagnosis of human tumours are reported. The specificities of individual MAbs of the 'C-series' presented here range from monospecificity for keratin No. 7 (MAbs C-18, C-35, C-62, and C-68), keratin No. 8 (MAbs C-15, C-43, and C-15), and keratin No. 18 (MAbs C-04 and C-08) up to the broadly reacting 'pan-keratin' MAb C-11, with the target epitopes of the remaining four MAbs being shared by different pairs of keratin polypeptides. The results of the biochemical characterization of the MAbs, together with their immunohistochemical staining patterns on frozen as well as on paraffin sections of normal human tissues, suggest that they represent a significant contribution to the growing list of anti-keratin MAbs applicable in both research and routine diagnostic pathology. The immunohistochemical examination of a wide range of human neoplasms with the new MAbs not only confirmed their value in making distinctions between carcinomas, on the one hand, and lymphomas, and gliomas, on the other, but also verified the possibility of more subtle subdivisions within the group of adenocarcinomas and their metastases. Furthermore, the identification of small subsets of breast carcinomas with decreased levels or apparent loss of the keratin No. 7 polypeptide and some cases of stomach carcinoma with apparently induced expression of this keratin suggests that such 'exceptions' must be considered when using keratin spectra as one of the criteria in differential diagnosis.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a monoklonální protilátky $x diagnostické užití $x imunologie $7 D000911
- 650 02
- $a specificita protilátek $7 D000918
- 650 02
- $a buněčné linie $7 D002460
- 650 02
- $a 2D gelová elektroforéza $7 D015180
- 650 02
- $a epitel $x imunologie $7 D004848
- 650 02
- $a fluorescenční protilátková technika $7 D005455
- 650 02
- $a lidé $7 D006801
- 650 02
- $a imunoblotting $7 D015151
- 650 02
- $a keratiny $x analýza $x imunologie $7 D007633
- 650 02
- $a myši $7 D051379
- 650 02
- $a nádory $x chemie $x imunologie $x patologie $7 D009369
- 700 1_
- $a Vojtěšek, Bořivoj, $d 1960- $7 xx0001694 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia
- 700 1_
- $a Stašková, Zdenka $7 xx0094306 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia
- 700 1_
- $a Bártková, Jiřina $7 xx0094304 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia
- 700 1_
- $a Kerekes, Zoltán, $d 1949- $7 xx0081398 $u Department of Pathology, Charles University Medical School, Hradec Králové, Czechoslovakia
- 700 1_
- $a Rejthar, Aleš, $d 1938-2015 $7 jk01102292 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia
- 700 1_
- $a Kovařík, Jan $7 xx0061134 $u Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia
- 773 0_
- $t Journal of Pathology $x 0022-3417 $g Roč. 164, č. 3 (1991), s. 215-224 $p J Pathol $w MED00002878
- 910 __
- $a ABA008 $b B 300 $y 3 $z 0
- 990 __
- $a 20130827135942 $b ABA008
- 991 __
- $a 20131203144919 $b ABA008
- 999 __
- $a ok $b bmc $g 991774 $s 826247
- BAS __
- $a 3
- BMC __
- $x MED00002878 $i 0022-3417 $a 1991 $b 164 $c 3 $d 215-224 $m Journal of pathology
- GRA __
- $a IZ95 $p MZ0
- GRA __
- $a IZ92 $p MZ0
- LZP __
- $a NLK 2013-08/lpbo